Stockreport

Viking Therapeutics (VKTX) Is Up 8.9% After Rival Data Bolsters Its Oral Obesity Program [Yahoo! Finance]

Viking Therapeutics, Inc.  (VKTX) 
Last viking therapeutics, inc. earnings: 4/30 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.vikingtherapeutics.com
PDF Phase 3 oral obesity study appeared to support Viking's own oral obesity drug program. This external validation of Viking's lead candidate VK2735 has sharpened investo [Read more]